This is a molecule-level guide to semaglutide in Toronto. Rather than focusing on a single brand, I cover how to choose between Ozempic, Wegovy, Rybelsus and the newly launched generic, when Torontonians can now get generic semaglutide at local pharmacies, why compounded semaglutide is not legal in Canada, and which telehealth services operate in the city. Pricing reflects April 2026 quotes.
If you already know which brand you need, jump to the Ozempic in Toronto guide for diabetes-focused pharmacy pricing or the Wegovy in Toronto guide for weight-management insurance details. For the full provincial view, read our semaglutide in Ontario hub.
What Semaglutide Means for Torontonians
Semaglutide is the active pharmaceutical ingredient in three Health Canada-approved brand products plus the newly launched generic [1]:
- Ozempic (injectable, 0.25 to 2.0 mg weekly). On-label for type 2 diabetes. Widely prescribed off-label for weight loss. Cash price $250 to $375 per month in Toronto.
- Wegovy (injectable, 0.25 to 2.4 mg weekly). On-label for chronic weight management (BMI 30+, or 27+ with comorbidity). Cash price $540 to $570 per month.
- Rybelsus (oral tablet, 3, 7 or 14 mg daily). On-label for type 2 diabetes. The oral option. Cash price roughly $250 to $300 per month.
- Generic semaglutide (injectable, launched May 2026 for diabetes). Manufactured by Apotex (Apo-Semaglutide) and Dr. Reddy's, with Sandoz, Teva Canada and others still under Health Canada review. Cash pharmacy price $88 to $120 per month for diabetes doses; $150 to $250 per month for the future 2.4 mg weight-management dose (Wegovy-equivalent), expected in late 2026 or early 2027 pending Health Canada approval.
Semaglutide Products Available in Toronto
Every major pharmacy chain in Toronto stocks all three brand semaglutide products as of April 2026 [2]. The table below summarizes how each compares for Torontonians.
| Product | Form | Indication | Typical Monthly Cost (April 2026) | Public Plan Status |
|---|---|---|---|---|
| Ozempic | Injectable (0.25 to 2.0 mg) | Type 2 diabetes (off-label for weight loss) | $250 to $375 | ODB Limited Use |
| Wegovy | Injectable (0.25 to 2.4 mg) | Chronic weight management | $540 to $570 | Not covered |
| Rybelsus | Oral tablet (3, 7 or 14 mg) | Type 2 diabetes | $250 to $300 | ODB Limited Use |
| Generic semaglutide | Injectable (various) | Diabetes first, weight management later | $88 to $120 | Under formulary review (2026–2027) |
Toronto has Canada’s deepest obesity-medicine and endocrinology specialist bench (UHN, St. Michael’s, Mount Sinai, Women’s College). That matters for semaglutide because product selection between Ozempic and Wegovy is often a specialist-led decision when BMI is borderline (27 to 30 with comorbidity).
Choosing Your Semaglutide Product in Toronto
Here’s a quick decision framework for Torontonians. Your prescribing clinician makes the final call.
If you have type 2 diabetes
Ozempic is the default because ODB lists it as a Limited Use benefit, your co-pay is typically the cheapest of the three brand options, and the weekly injection is convenient. Rybelsus is useful if you prefer an oral tablet or have a needle aversion. See the Ozempic in Toronto guide for pharmacy-by-pharmacy pricing.
If you have obesity and a BMI of 30 or higher
Wegovy is the Health Canada-approved product for chronic weight management. ODB does not cover Wegovy, so your best path to a lower monthly cost is private insurance with prior authorization. See the Wegovy in Toronto guide for BMI eligibility and prior-auth paperwork.
If you want the cheapest legal option
Consider generic semaglutide. It launched in Canadian pharmacies in May 2026 at about $88 to $120 per month for the diabetes dose [3]. Generic semaglutide (Apo-Semaglutide from Apotex, Dr. Reddy's generic) is now the cheapest cash option in Toronto at roughly $88 to $99 per month at Costco Pharmacy, well below brand Ozempic at $250 to $310. Toronto-area Costco warehouses: Downtown (Queens Quay); Etobicoke (Queensway); Scarborough (Warden); North York (Billy Bishop area).
Generic Semaglutide Launch in Toronto
Novo Nordisk’s Canadian data exclusivity on semaglutide expired on January 4, 2026 [4]. Health Canada has now authorized two generic manufacturers, Dr. Reddy's Laboratories (April 28, 2026) and Apotex Inc. (May 1, 2026). Additional applications from Sandoz, Teva Canada and other manufacturers remain under review. Both shipped to Canadian pharmacies for type 2 diabetes (Ozempic-equivalent) on May 20, 2026. A generic 2.4 mg weight-management dose (Wegovy-equivalent) will likely follow by late 2026 or early 2027, with generic cash prices expected to ease further as more manufacturers launch and several provinces review the generic for public-plan coverage [3].
Toronto is likely to be among the first Canadian cities to see generic semaglutide on pharmacy shelves. Costco GTA warehouses, Shoppers Drug Mart and the Rexall network typically receive national launches within two weeks. Independent pharmacies in Yorkville and the Annex follow within 30 days.
For the national timeline and manufacturer detail, read our generic semaglutide guide.
Compounded Semaglutide: Not a Legal Option in Toronto
Health Canada prohibits the compounding of semaglutide by community pharmacies [5]. Any website or clinic advertising "compounded semaglutide" in Toronto is operating outside Canadian drug-safety regulation. Product purity, sterility and potency cannot be verified. Serious adverse events have been reported in the U.S. from compounded GLP-1 use.
- Compounded semaglutide has not been reviewed by Health Canada for safety, quality or efficacy.
- Provincial colleges of pharmacists in Ontario prohibit licensed pharmacies from dispensing compounded semaglutide.
- Health Canada issued public warnings against compounded weight-loss drugs in 2023 and 2024.
If you encounter a telehealth service offering "compounded semaglutide" in Toronto, it is either (a) not operating legally in Canada or (b) referring you to an unregulated U.S. source. Stick with Health Canada-approved Ozempic, Wegovy, Rybelsus or the now-available generic.
Telehealth vs In-Person Semaglutide in Toronto
Both paths are widely available to Torontonians. Here’s how the six Canadian telehealth services compare.
Top pick: MyRocky (operated by Rocky Health Inc.) is our highest-rated Canadian GLP-1 provider in 2026 (9.4/10). Per-pen pricing is roughly comparable across the major Canadian telehealth services - what MyRocky wins on is total value: the $99 one-time consult includes lab work and the first prescription, there are no recurring quarterly fees, free fast delivery is included, and it operates its own LegitScript-certified pharmacy in Mississauga. MyRocky also serves all 10 provinces (Felix and Hims do not operate in Quebec) and has been trusted by 350,000+ Canadians. Visit MyRocky or read our full MyRocky review.
| Provider | Monthly Program Cost | Consultation Fee | Coverage | Learn More |
|---|---|---|---|---|
| MyRocky ⭐ Top Pick | $300–$310 | $99 once (lab work included) | All 10 provinces | Visit MyRocky |
| Felix Health | Brand $250–$310 / Generic $149 | $99 setup + $40 quarterly | All provinces except QC | Visit Felix |
| Maple | $270–$320 | $69 per consult | All provinces | Visit Maple |
| Hims Canada | Generic $149 all-in | Included | Select provinces | Visit Hims |
| Jill Health | Pricing on assessment | Included in program | Most provinces | Visit Jill |
| DooU | Pricing on assessment | Included in program | Most provinces | Visit DooU |
| Raven | Pricing on assessment | Included in program | Most provinces | Visit Raven |
Provider reviews: MyRocky (top pick), Felix, Maple, Hims Canada, Jill Health, DooU and Raven.
All six telehealth services on this list accept new patients from Toronto as of April 2026.
Cost of Semaglutide in Toronto
Your monthly cost depends on which product you take and where you fill it. Quick overview for Toronto:
- Ozempic 1.0 mg: $250 to $375 per month brand cash; Costco is cheapest at about $250 to $265.
- Wegovy 2.4 mg: $540 to $570 per month brand cash; Costco is cheapest at $490 to $520.
- Rybelsus 14 mg: $250 to $300 per month brand cash; similar to Ozempic pricing.
- Generic semaglutide (now available for diabetes): $88 to $120 per month depending on indication and dose.
For in-depth pharmacy-by-pharmacy pricing, see the brand-specific city pages: Ozempic in Toronto and Wegovy in Toronto. For national pricing comparison, see our semaglutide cost guide.
Clinical Evidence Behind Semaglutide
Semaglutide has the strongest randomized-trial evidence base of any GLP-1 receptor agonist. Key studies Torontonians should know about:
- SUSTAIN-6 (2016). Injectable semaglutide (Ozempic) reduced major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease [6].
- STEP 1 (2021). Semaglutide 2.4 mg (Wegovy) produced a mean weight loss of roughly 14.9 percent over 68 weeks in adults with obesity, vs 2.4 percent on placebo [7].
- SELECT (2023). Semaglutide 2.4 mg reduced major adverse cardiovascular events by 20 percent in adults with overweight or obesity and established cardiovascular disease, without type 2 diabetes [8].
FAQ
Which semaglutide product is the cheapest in Toronto right now?
For type 2 diabetes, Ozempic at Costco pharmacy runs about $250 to $265 per month in Toronto. For weight management, Wegovy at Costco runs $490 to $520 per month. Generic semaglutide already undercuts both, available since May 2026.
Is semaglutide the same as Ozempic in Toronto?
Semaglutide is the active ingredient. Ozempic is a Health Canada-approved brand of injectable semaglutide for type 2 diabetes. Wegovy is the higher-dose brand for chronic weight management. Rybelsus is the oral tablet. All three are sold across Toronto.
Is generic semaglutide available at Toronto pharmacies?
Yes. Apotex's Apo-Semaglutide Injection and Dr. Reddy's generic launched in Canadian pharmacies in May 2026 and are now reaching Toronto pharmacy shelves. Costco Pharmacy in Toronto is the lowest cash price at roughly $88 to $99 per month; Walmart and No Frills run $95 to $110; Shoppers Drug Mart, Rexall and London Drugs run $100 to $120. Felix Health and Hims Canada both offer it through telehealth at $149 per month all-in.
Can I buy compounded semaglutide in Toronto?
No. Health Canada and the Ontario college of pharmacists prohibit compounded semaglutide. Any service offering it in Toronto is operating outside Canadian drug-safety regulation. Stick with Health Canada-approved Ozempic, Wegovy, Rybelsus or the now-available generic.
Does ODB cover any semaglutide product for Torontonians?
ODB lists Ozempic and Rybelsus as Limited Use benefits for type 2 diabetes. Wegovy for weight management is never covered by ODB. Full provincial rules live on our Semaglutide in Ontario page.
Can telehealth services prescribe semaglutide in Toronto?
Yes in most cases. Torontonians can access Ozempic, Wegovy and Rybelsus through Canadian telehealth services after an online assessment. All six Canadian telehealth services on this list serve Toronto.
Which pharmacy chain in Toronto will get generic semaglutide first?
Toronto is likely to be among the first Canadian cities to see generic semaglutide on pharmacy shelves. Costco GTA warehouses, Shoppers Drug Mart and the Rexall network typically receive national launches within two weeks. Independent pharmacies in Yorkville and the Annex follow within 30 days.
This article is informational and is not a substitute for medical advice from your prescribing clinician. Always confirm pricing directly with the pharmacy before filling.
Sources
- Health Canada: Semaglutide (Ozempic, Wegovy, Rybelsus) Product Monographs: Official Canadian product monographs for all three Health Canada-approved semaglutide brands.
- Ontario Drug Benefit: Official Program Information: Provincial drug plan rules and formulary lookup for Ontario, including Toronto.
- Patented Medicine Prices Review Board: Generic Drug Pipeline (2026): Industry reporting on generic semaglutide submissions under Health Canada review.
- Semaglutide Canada: Generic Semaglutide in Canada: Full national timeline on generic semaglutide launch, manufacturers and pricing.
- Health Canada: Advisory on Compounded Semaglutide and Other Weight-Loss Products: Public warnings on unauthorized compounded semaglutide products and related safety concerns.
- SUSTAIN-6: Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes (NEJM, 2016): Landmark cardiovascular outcomes trial for Ozempic.
- STEP 1: Once-Weekly Semaglutide in Adults with Overweight or Obesity (NEJM, 2021): Landmark randomized trial establishing Wegovy efficacy for chronic weight management.
- SELECT: Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (NEJM, 2023): Landmark trial showing cardiovascular benefit of Wegovy in non-diabetic adults with obesity.
- Drug Shortages Canada: Health Canada-run site tracking current semaglutide supply status across Canada.
- Canadian Agency for Drugs and Technologies in Health (CADTH): Semaglutide Reimbursement Review: CADTH reimbursement guidance used by provincial drug plans for semaglutide.